Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of Sanqi Longxuejie Capsules for stable effort angina in coronary heart disease
CTR20220904Phase 4Active
- Sponsor
- Dihon Pharmaceutical Group Co., Ltd.
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sanqi Longxuejie in coronary arteriosclerosis, stable angina, sponsored by Dihon Pharmaceutical Group Co., Ltd.. Started Jul 2022; status: active.
02
Drugs
Sanqi Longxuejie
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20220904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220904.